Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis: A Consensus Statement

Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values

Tibbling, G., Link, H., & Ohman, S. (1977) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365517709091496 · Cited by 971

Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs

Reiber, H., & Peter, J. B. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00501-3 · Cited by 740

Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

Qin, Y., Duquette, P., Zhang, Y., Talbot, P. J., Poole, R., & Antel, J. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3568 · Cited by 323

The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis

Reiber, H., Ungefehr, S., & Jacobi, C. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400304 · Cited by 305

A STUDY OF IMMUNOGLOBULIN G IN THE CEREBROSPINAL FLUID OF 1007 PATIENTS WITH SUSPECTED NEUROLOGICAL DISEASE USING ISOELECTRIC FOCUSING AND THE LOG IgG-INDEX

McLean, B., Luxton, R. W., & Thompson, E. J. (1990) · Brain · doi:10.1093/brain/113.5.1269 · Cited by 206

Oligoclonal Measles Virus‐Specific IgG Antibodies Isolated from Cerebrospinal Fluids, Brain Extracts, and Sera from Patients with Subacute Sclerosing Panencephalitis and Multiple Sclerosis

Vandvik, B., Norrby, E., Nordal, H. J., & DECRÉ, M. (1976) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1976.tb03050.x · Cited by 194

A study of oligoclonal band negative multiple sclerosis.

Zeman, A. Z., Kidd, D. P., McLean, B., Kelly, M. A., Francis, D. A., Miller, D. H., Kendall, B. E., Rudge, P., Thompson, E. J., & McDonald, W. I. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.1.27 · Cited by 161

IgG production within the central nervous system: A critical review of proposed formulae

Lefvert, A. K., & Link, H. (1985) · Annals of Neurology · doi:10.1002/ana.410170105 · Cited by 129

Oligoclonal IgG Bands in Cerebrospinal Fluid

Kostulas, V. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520220043014 · Cited by 119

Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions

O’Connor, K. C., Chitnis, T., Griffin, D. E., Piyasirisilp, S., Bar‐Or, A., Khoury, S. J., Wucherpfennig, K. W., & Hafler, D. A. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00002-x · Cited by 98

Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice

Spelman, T. D., Meyniel, C., Rojas, J. I., Lugaresi, A., Izquierdo, G., Grand’Maison, F., Boz, C., Alroughani, R., Havrdová, E., Horáková, D., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516679893 · Cited by 26

A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band

On behalf of the RIREMS group (Rising Italian Researchers in Multiple Sclerosis), Ferraro, D., Franciotta, D. M., Bedin, R., Solaro, C. M., Cocco, E. E., Santangelo, M., Immovilli, P., Gajofatto, A., Calabrese, M., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8480-5 · Cited by 26

Cerebrospinal fluid findings in non-infectious status epilepticus

Malter, M. P., Choi, S., & Fink, G. R. (2017) · Epilepsy Research · doi:10.1016/j.eplepsyres.2017.12.008 · Cited by 26

Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosis

Bsteh, G., Hegen, H., Altmann, P., Auer, M., Berek, K., Pauli, F. D., Haider, L., Kornek, B., Krajnc, N., Leutmezer, F., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.15718 · Cited by 25

Retinoic acid enhances the levels of IL-10 in TLR-stimulated B cells from patients with relapsing–remitting multiple sclerosis

Eriksen, A. B., Berge, T., Gustavsen, M. W., Leikfoss, I. S., Bos, S. D., Spurkland, A., Harbo, H. F., & Blomhoff, H. K. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.11.019 · Cited by 25

Practice patterns of US neurologists in patients with CIS, RRMS, or RIS

Tornatore, C., Phillips, J. T., Khan, O., Miller, A., & Barnes, C. J. (2012) · Neurology Clinical Practice · doi:10.1212/cpj.0b013e31824cb09b · Cited by 25

DNase hypersensitive sites and association with multiple sclerosis

Disanto, G., Sandve, G. K., Ricigliano, V. A. G., Pakpoor, J., Berlanga‐Taylor, A. J., Handel, A. E., Kühle, J., Holden, L., Watson, C. T., Giovannoni, G., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt489 · Cited by 25

Immunopathology of Japanese macaque encephalomyelitis is similar to multiple sclerosis

Blair, T. C., Manoharan, M., Rawlings-Rhea, S. D., Tagge, I., Kohama, S. G., Hollister‐Smith, J. A., Ferguson, B. M., Woltjer, R. L., Frederick, M. C., Pollaro, J., et al. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.11.026 · Cited by 25

Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis

Degn, M., Modvig, S., Dyring‐Andersen, B., Bonefeld, C. M., Frederiksen, J. L., Geisler, C., & von Essen, M. R. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515609795 · Cited by 25

Routine Cerebrospinal Fluid (CSF) Analysis

Deisenhammer, F., Bartoš, A., Egg, R., Gilhus, N. E., Giovannoni, G., Rauer, S., Sellebjerg, F. T., & Tumani, H. (2010) · Wiley eBooks · doi:10.1002/9781444328394.ch1 · Cited by 25

Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serum

Berek, K., Bauer, A., Rudzki, D., Auer, M., Barket, R., Zinganell, A., Lerch, M., Hofer, L., Grams, A. E., Poskaite, P., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1200146 · Cited by 25

A Prospective Study of Patients with Brain MRI Showing Incidental T2 Hyperintensities Addressed as Multiple Sclerosis: a Lot of Work to do Before Treating

Lebrun‐Frénay, C., Cohen, M., Chaussenot, A., Mondot, L., & Chanalet, S. (2014) · Neurology and Therapy · doi:10.1007/s40120-014-0024-7 · Cited by 26

Antigen‐specific oligoclonal bands in cerebrospinal fluid and serum from patients with anti‐amphiphysin‐ and anti‐CV2/CRMP5 associated paraneoplastic neurological syndromes

Stich, O., & Rauer, S. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01802.x · Cited by 24

Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG

Zeman, D., Hradílek, P., Kušnierová, P., Piza, R., Reguliová, K., Woznicová, I., & Zapletalová, O. (2014) · Biomedical Papers · doi:10.5507/bp.2014.058 · Cited by 24

Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis

Bernitsas, E., Khan, O. A., Razmjou, S., Tselis, A. C., Bao, F., Caon, C., Millis, S. R., & Seraji‐Bozorgzad, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181431 · Cited by 24

Cerebrospinal fluid findings in patients with psychotic symptoms—a retrospective analysis

Rattay, T. W., Martin, P., Vittore, D., Hengel, H., Cebi, I., Tünnerhoff, J., Stefanou, M., Hoffmann, J., von der Ehe, K., Klaus, J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86170-w · Cited by 25

Study of oligoclonal bands restricted to the cerebrospinal fluid in multiple sclerosis patients in the city of São Paulo

da Gama, P. D., Machado, L. D. R., LIVRAMENTO, J. A., Gomes, H. R., Adoni, T., Lino, A. M. M., Marchiori, P. E., Morales, R. R., Lana–Peixoto, M. A., & Callegaro, D. (2009) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2009000600011 · Cited by 24

Molecular biomarkers in multiple sclerosis

Michaličková, D., Kübra, Ö., Das, D., Osama, B., & Slanař, O. (2022) · Arhiv za farmaciju · doi:10.5937/arhfarm72-36165 · Cited by 23

B cells from patients with multiple sclerosis have a pathogenic phenotype and increased LTα and TGFβ1 response

McWilliam, O. H., Sellebjerg, F. T., Marquart, H. V., & von Essen, M. R. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.09.001 · Cited by 24

Myelinoclastic diffuse sclerosis (Schilder’s disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures

Jarius, S., Haas, J., Paul, F., & Wildemann, B. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1425-4 · Cited by 23

Does CSF pleocytosis have a predictive value for disease course in MS?

Lotan, I., Benninger, F., Mendel, R., Hellmann, M. A., & Steiner, I. (2019) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000584 · Cited by 23

High Resolution Protein Electrophoresis of 100 Paired Canine Cerebrospinal Fluid and Serum

Behr, S., Trumel, C., Cauzinille, L., Palenché, F., & Braun, J.-P. (2006) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2006.tb02911.x · Cited by 22

Progressive Multifocal Leukoencephalopathy, Natalizumab, and Multiple Sclerosis

Álvarez‐Cermeño, J. C., Masjuán, J., & Villar, L. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmc052311 · Cited by 22

Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement

Matysiak, M., Oset, M., Domowicz, M., Gałązka, G., Namiecińska, M., & Stasiołek, M. (2023) · Biomedicines · doi:10.3390/biomedicines11020425 · Cited by 22

Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis

da Gama, P. D., Machado, L. D. R., LIVRAMENTO, J. A., Gomes, H. R., Adoni, T., Morales, R. R., da Gama, R. A. D., Diniz, D., Lana–Peixoto, M. A., Fragoso, Y. D., et al. (2015) · BioMed Research International · doi:10.1155/2015/217961 · Cited by 21

Modern multiple sclerosis treatment – what is approved, what is on the horizon

Pilz, G., Wipfler, P., Ladurner, G., & Kraus, J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.08.003 · Cited by 21

CSF albumin and immunoglobulin analyses in childhood neurologic disorders

Hacohen, Y., Singh, R. R., Forsyth, V., Absoud, M., & Lim, M. J. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000010 · Cited by 21

Recommendations for cerebrospinal fluid analysis

Hepnar, D., Adam, P., Žáková, H., Krušina, M., Kalvach, P., Kasík, J., Karpowicz, I., Nasler, J., Bechyně, K., Fiala, T., et al. (2018) · Folia Microbiologica · doi:10.1007/s12223-018-0663-7 · Cited by 21

The effect of B-cell depletion in the Theiler's model of multiple sclerosis

Gilli, F., Li, L., Campbell, S. J., Anthony, D. C., & Pachner, A. R. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.10.012 · Cited by 21

Cerebrospinal Fluid IgM and Oligoclonal IgG Bands in Multiple Sclerosis: A Meta-Analysis of Prevalence and Prognosis

Fonderico, M., Portaccio, E., Razzolini, L., Pastò, L., Bellinvia, A., Addazio, I., Betti, M., Aprea, M. G., Ballerini, C., Biagioli, T., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11111444 · Cited by 22

Multiple Sclerosis: From the Application of Oligoclonal Bands to Novel Potential Biomarkers

Maglio, G., D’Agostino, M., Caronte, F. P., Pezone, L., Casamassimi, A., Rienzo, M., Zazzo, E. D., Nappo, C., Medici, N., Molinari, A. M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105412 · Cited by 21

Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients

Stich, O., Kluge, J., Speck, J., & Rauer, S. (2014) · Acta Neurologica Scandinavica · doi:10.1111/ane.12350 · Cited by 20

Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time

Jacobi, C., Hähnel, S., Martinez-Torres, F. J., Rieger, S., Jüttler, E., Heiland, S., Jarius, S., Meyding‐Lamadé, U., Storch-Hagenlocher, B., & Wildemann, B. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02315.x · Cited by 20

The role of Candida albicans in the severity of multiple sclerosis

Saroukolaei, S. A., Ghabaee, M., Shokri, H., Badiei, A., & Ghourchian, S. (2016) · Mycoses · doi:10.1111/myc.12489 · Cited by 20

Relevance of KFLC quantification to differentiate clinically isolated syndrome from multiple sclerosis at clinical onset

Vasilj, M., Kes, V. B., Vrkić, N., & Vukasović, I. (2018) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2018.09.031 · Cited by 21

Exploring cDNA Phage Display for Autoantibody Profiling in the Serum of Multiple Sclerosis Patients

Govarts, C., Somers, K., Hupperts, R., Stinissen, P., & Somers, V. A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.043 · Cited by 20

Increased Female MS Incidence and Differences in Gender-Specific Risk in Medium- and High-Risk Regions in Finland from 1981–2010

Holmberg, M., Murtonen, A., Elovaara, I., & Sumelahti, M. (2013) · Multiple Sclerosis International · doi:10.1155/2013/182516 · Cited by 20

Oligoclonal bands in tears

Lolli, F., & Franciotta, D. M. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510367663 · Cited by 20

Persistently Gadolinium-Enhancing Lesion Is a Predictor of Poor Prognosis in NMOSD Attack: a Clinical Trial

Xu, Y., Ren, Y. L., Li, X., Xu, W., Wang, X., Duan, Y., Liu, Y., Zhang, X., & Tian, D. (2021) · Neurotherapeutics · doi:10.1007/s13311-020-00973-9 · Cited by 19

CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma

Ungureanu, A., Garff‐Tavernier, M. L., Costopoulos, M., Parratte, T., Brinet, A., Durand, H., Gaultier, C., Hurstel, R., Alamome, I., Sellal, F., et al. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10453-5 · Cited by 19

Kappa-index: Real-life evaluation of a new tool for multiple sclerosis diagnosis

Marlas, M., Bost, C., Dorcet, G., Delourme, A., Biotti, D., Ciron, J., Renaudineau, Y., & Puissant‐Lubrano, B. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109066 · Cited by 19

Cerebrospinal fluid and urinary biomarkers in multiple sclerosis

Dobson, R., Topping, J., Davis, A., Thompson, E. J., & Giovannoni, G. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12119 · Cited by 19

Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event

Gout, O., Bouchareine, A., Moulignier, A., Deschamps, R., Papeix, C., Gorochov, G., Héran, F., & Bastuji‐Garin, S. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510385506 · Cited by 19

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity

Karathanasis, D., Rapti, A., Nezos, A., Skarlis, C., Kilidireas, C., Mavragani, C. P., & Evangelopoulos, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.898049 · Cited by 19

Features of intrathecal immunoglobulins in patients with multiple sclerosis

Pauli, F. D., Gredler, V., Kuenz, B., Lutterotti, A., Ehling, R., Gneiss, C., Schocke, M. F. H., Deisenhammer, F., Reindl, M., & Berger, T. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.016 · Cited by 19

Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study

Wurth, S., Kuenz, B., Bsteh, G., Ehling, R., Pauli, F. D., Hegen, H., Auer, M., Gredler, V., Deisenhammer, F., Reindl, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182462 · Cited by 20

Increased cerebrospinal fluid albumin and immunoglobulin A fractions forecast cortical atrophy and longitudinal functional deterioration in relapsing-remitting multiple sclerosis

Kroth, J., Ciolac, D., Fleischer, V., Koirala, N., Krämer, J., Muthuraman, M., Luessi, F., Bittner, S., González‐Escamilla, G., Zipp, F., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517748474 · Cited by 19

Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables

Oviedo-Salcedo, T., Wagner, E. M., Campana, M., Gagsteiger, A., Strube, W., Eichhorn, P., Louiset, M.-L., Luykx, J. J., de Witte, L. D., Kahn, R. S., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01751-7 · Cited by 19

Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis

Konen, F. F., Hannich, M. J., Schwenkenbecher, P., Grothe, M., Gag, K., Jendretzky, K. F., Gingele, S., Sühs, K., Witte, T., Skripuletz, T., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10071629 · Cited by 18

Toxic Air Pollutants and Their Effect on Multiple Sclerosis: A Review Study

Mohammadi, M. J., Zarea, K., Hatamzadeh, N., Salahshouri, A., & Sharhani, A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.898043 · Cited by 19

Genomic Regions Associated with Multiple Sclerosis Are Active in B Cells

Disanto, G., Sandve, G. K., Berlanga‐Taylor, A. J., Morahan, J. M., Dobson, R., Giovannoni, G., & Ramagopalan, S. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032281 · Cited by 18

Capillary isoelectric focusing immunoassay as a new nanoscale approach for the detection of oligoclonal bands

Halbgebauer, S., Haußmann, U., Klafki, H., Tumani, H., Wiltfang, J., & Otto, M. (2014) · Electrophoresis · doi:10.1002/elps.201400339 · Cited by 18

Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis

Dagley, L. F., Emili, A., & Purcell, A. W. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200104 · Cited by 19

Disruption of blood-brain barrier integrity associated with brain lesions in Chinese neuromyelitis optica spectrum disorder patients

You, X., Yan, L., Li, X., Pang, Y., Guo, X., Ye, J., & Hu, H. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.10.114 · Cited by 18

The Neuroimmunology of Multiple Sclerosis: Fictions and Facts

Pachner, A. R. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.796378 · Cited by 19

The Role of Quantitative Neuroimaging Indices in the Differentiation of Ischemia From Demyelination: An Analytical Study With Case Presentation

Hoque, R., Ledbetter, C. R., Gonzalez‐Toledo, E., Misra, V., Menon, U., Kenner, M., Rabinstein, A. A., Kelley, R. E., Zivadinov, R., & Minagar, A. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79022-0 · Cited by 18

Clinical features and disability progression in multiple sclerosis in Tunisia: Do we really have a more aggressive disease course?

Sidhom, Y., Damak, M., Riahi, A. D., Hizem, Y., Mrissa, R., Mhiri, C., & Gouider, R. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.05.049 · Cited by 18

The Kappa Free Light Chains Index and Central Vein Sign: Two New Biomarkers for Multiple Sclerosis Diagnosis

Levraut, M., Landes-Château, C., Mondot, L., Cohen, M., & Lebrun‐Frénay, C. (2025) · Neurology and Therapy · doi:10.1007/s40120-025-00737-7 · Cited by 19

Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain Measurements

Natali, P., Bedin, R., Bernardi, G., Corsini, E., Cocco, E. E., Schirru, L., Crespi, I., Lamonaca, M., Sala, A., Nicolò, C., et al. (2022) · Biomolecules · doi:10.3390/biom12050677 · Cited by 17

Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis

Monreal, E., Fernández-Velasco, J. I., García-Soidán, A., de la Maza, S. S., Espiño, M., Villarrubia, N., Rodríguez‐Jorge, F., Chico‐García, J. L., Sainz-Amo, R., Masjuán, J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1288169 · Cited by 19

Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis

Halbgebauer, S., Huss, A. M., Buttmann, M., Steinacker, P., Oeckl, P., Brecht, I., Weishaupt, A., Tumani, H., & Otto, M. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8094-3 · Cited by 17

Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis

McComb, M., Krikheli, M., Uher, T., Browne, R. W., Srpová, B., Oechtering, J., Maceski, A. M., Týblová, M., Jakimovski, D., Ramasamy, D. P., et al. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.07.001 · Cited by 17

Kappa free light chains: Diagnostic performance in multiple sclerosis and utility in a clinical laboratory

Martins, D. A., Lopes, J., SILVA, A. C. F. D., Morais, C. I., Vasconcelos, J. H. L., Lima, I., Carneiro, C. S., & Neves, E. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.01.017 · Cited by 18

Oligoclonal bands: An immunological and clinical approach

Cabrera, C. M. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.03.004 · Cited by 17

Revisión de la esclerosis múltiple (2). Diagnóstico y tratamiento

Martinez-Altarriba, M. C., Ramos‐Campoy, O., Luna-Calcaño, I. M., & Arrieta-Antón, E. (2014) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2014.07.011 · Cited by 16

Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series

Fonderico, M., Biagioli, T., Lanzilao, L., Bellinvia, A., Fratangelo, R., Pastò, L., Prestipino, E., Razzolini, L., Tudisco, L., Ginestroni, A., et al. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520907913 · Cited by 17

Diagnostic value of kappa free light chains in patients with one isolated band in isoelectric focusing

Süße, M., Feistner, F., Holbe, C., Grothe, M., Nauck, M. A., Dressel, A., & Hannich, M. J. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.04.029 · Cited by 16

Cerebrospinal fluid oligoclonal bands in Neuroborreliosis are specific for Borrelia burgdorferi

Berek, K., Hegen, H., Auer, M., Zinganell, A., Pauli, F. D., & Deisenhammer, F. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239453 · Cited by 19

IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis

Petržalka, M., Meluzínová, E., Libertínová, J., Mojžišová, H., Hanzalová, J., Ročková, P., Elišák, M., Kmetonyová, S., Šanda, J., Sobek, O., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270607 · Cited by 16

Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin

Prümmer, J. K., Stein, V. M., Marti, E., Lutterotti, A., Jelčić, I., Schüpbach‐Regula, G., Buch, T., & Maiolini, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280864 · Cited by 20

Routine Cerebrospinal Fluid (CSF) Analysis

Deisenhammer, F., Bartoš, A., Egg, R., Gilhus, N. E., Giovannoni, G., Rauer, S., & Sellebjerg, F. T. (2006) · Wiley eBooks · doi:10.1002/9780470753279.ch4 · Cited by 16

Applying the 2017 McDonald diagnostic criteria for multiple sclerosis

Petzold, A. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30159-5 · Cited by 17

Oligoclonal bands

Willis, M., Kreft, K. L., & Dancey, B. (2024) · Practical Neurology · doi:10.1136/pn-2023-003814 · Cited by 16

Kappa index for multiple sclerosis diagnosis: an accurate biomarker of intrathecal synthesis

Vecchio, D., Puricelli, C., Virgilio, E., Passarelli, F., Guida, S., Naldi, P., Crespi, I., Dianzani, U., & Comi, C. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12826-y · Cited by 17

CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective

Sabatino, E. D., Ferraro, D., Gaetani, L., Emiliano, E., Parnetti, L., & Filippo, M. D. (2025) · Journal of Neurology · doi:10.1007/s00415-025-12907-6 · Cited by 17

Free complement and complement containing extracellular vesicles as potential biomarkers for neuroinflammatory and neurodegenerative disorders

Burgelman, M., Dujardin, P., Vandendriessche, C., & Vandenbroucke, R. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1055050 · Cited by 16

Diagnostic modalities in multiple sclerosis: Perspectives in children

Wang, H.-S., Tănăsescu, R., Constantinescu, C. S., Chou, I., & Whitehouse, W. P. (2014) · Biomedical Journal · doi:10.4103/2319-4170.129269 · Cited by 16

Isoelectric focusing is superior to immunofixation electrophoresis in diagnosing CNS inflammation

Mygland, Å., Trydal, T., Vinje, B. U., & Vedeler, C. A. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00763.x · Cited by 15

Therapeutic Application of Monoclonal Antibodies in Multiple Sclerosis

Orthmann‐Murphy, J. L., & Calabresi, P. A. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.547 · Cited by 15

Cerebrospinal, Synovial, Serous Body Fluids, and Alternative Specimens

Karcher, D. S., & McPherson, R. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00029-4 · Cited by 15

Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection

Gudowska-Sawczuk, M., & Mroczko, B. (2019) · BioMed Research International · doi:10.1155/2019/8382132 · Cited by 14

Peptidylarginine Deiminase 2 Autoantibodies Are Linked to Less Severe Disease in Multiple Sclerosis and Post-treatment Lyme Disease

Kim, Y., Rebman, A. W., Johnson, T. P., Wang, H., Yang, T., Colantuoni, C., Bhargava, P., Levy, M., Calabresi, P. A., Aucott, J. N., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.874211 · Cited by 13

Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities

Napodano, C., Pocino, K., Gulli, F., Rossi, E. G., Rapaccini, G. L., Marino, M., & Basile, U. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.08.002 · Cited by 13

Cholesterol levels in plasma and cerebrospinal fluid in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis

Evangelopoulos, M., Koutsis, G., Boufidou, F., & Markianos, M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105889 · Cited by 13

Blood–brain barrier dysfunction and folate and vitamin B12 levels in first-episode schizophrenia-spectrum psychosis: a retrospective chart review

Campana, M., Löhrs, L., Strauß, J., Muenz, S., Oviedo-Salcedo, T., Fernando, P., Maurus, I., Raabe, F. J., Moussiopoulou, J., Eichhorn, P., et al. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01572-3 · Cited by 13

Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research

Fawaz, C. N., Makki, I., Kazan, J. M., Gebara, N. Y., Andary, F. S., Itani, M. M., El-Sayyed, M., Zeidan, A., Quartarone, A., Darwish, H., et al. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1099435 · Cited by 13

Cerebrospinal fluid analysis in the context of CNS demyelinating diseases

Matas, S. L. D. A., von Glehn, F., Fernandes, G. B. P., & Soares, C. A. S. (2013) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20130151 · Cited by 13

Positivity of oligoclonal bands in the cerebrospinal fluid predisposed to metabolic changes and rearrangement of inhibitory/excitatory neurotransmitters in subcortical brain structures in multiple sclerosis

Kantorová, E., Hnilicová, P., Bogner, W., Grendár, M., Čierný, D., Hečková, E., Strasser, B., Ružiňák, R., Zeleňák, K., & Kurča, E. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102978 · Cited by 13

Hypersensitivity Responses in the Central Nervous System

Khorooshi, R., Asgari, N., Mørch, M. T., Berg, C. T., & Owens, T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00517 · Cited by 13

Characteristics of cerebrospinal fluid oligoclonal band in anti-myelin oligodendrocyte glycoprotein (MOG) antibody associated disease

Shao, W., Liu, X., Li, J., Sheng, T., Li, Y., Gu, Y., Deng, B., Wang, J., Yang, W., Yu, H. J., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24742 · Cited by 13

CSF oligoclonal bands in neurological diseases besides CNS inflammatory demyelinating disorders

Ren, J., Wang, J., Liu, R., Guo, J., Yao, Y., Hao, H.-J., & Gao, F. (2025) · BMJ Neurology Open · doi:10.1136/bmjno-2024-000912 · Cited by 12

Kappa Free Light Chain Index in the Real World—Do We Miss Clinically Relevant Information by Skipping Oligoclonal Banding?

Hegen, H., Schmidauer, M., Auer, M., Pauli, F. D., Berek, K., Walde, J., & Deisenhammer, F. (2025) · European Journal of Neurology · doi:10.1111/ene.70355 · Cited by 12

Inter-center agreement in the interpretation of oligoclonal bands

Mariotto, S., Ferraro, D., Soldani, F., Alberti, D., Bedin, R., Sola, P., Gastaldi, M., Franciotta, D. M., & Ferrari, S. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1037 · Cited by 12

Sex-Related Differences in Cerebrospinal Fluid Plasma-Derived Proteins of Neurological Patients

Castellazzi, M., Ferri, C., Alfiero, S., Lombardo, I., Laudisi, M., Tecilla, G., Boni, M., Pizzicotti, S., Fainardi, E., Bellini, T., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11050884 · Cited by 12

IgM to S-nitrosylated protein is found intrathecally in relapsing–remitting multiple sclerosis

Hvaring, C., Vujicic, S., Aasly, J. O., Feinstein, D. L., White, L. R., & Boullerne, A. I. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.12.011 · Cited by 12

Comparison of neurophysiological and mri findings of patients with multiple sclerosis using oligoclonal band technique

Elli̇dağ, H. Y., Eren, E., Erdoğan, N., Türe, S., & Yılmaz, N. (2013) · Annals of Neurosciences · doi:10.5214/ans.0972.7531.200406 · Cited by 12

Application of the 2017 McDonald criteria in a Chinese population with clinically isolated syndrome

Zheng, Y., Shen, C., Wang, S., Yang, F., Cai, M., Fang, W. J., Zhang, Y., & Ding, M. (2020) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419898083 · Cited by 13

Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients

Calabrese, M., Marastoni, D., Crescenzo, F., & Scalfari, A. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000921 · Cited by 12

Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis

Zéphir, H., Lefranc, D., Dubucquoi, S., Seze, J. D., Boron, L., Prin, L., & Vermersch, P. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458508101951 · Cited by 12

The prevalence of autoimmune diseases in patients with multiple sclerosis: A cross-sectional study in Qom, Iran, in 2018

Ershadinia, N., Mortazavinia, N., Babaniamansour, S., Najafi-Nesheli, M., Babaniamansour, P., & Aliniagerdroudbari, E. (2021) · Current Journal of Neurology · doi:10.18502/cjn.v19i3.5421 · Cited by 12

Cerebrospinal Fluid Analysis in Multiple Sclerosis

Luque, F. A., & Jaffe, S. L. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79015-3 · Cited by 36

CSF testing for multiple sclerosis

Pender, M. P. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70151-4 · Cited by 2

Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Andersson, M., Alvarez-Cermeno, J., Bernardi, G., Cogato, I., Fredman, P., Frederiksen, J., Fredrikson, S., Gallo, P., Grimaldi, L. M., Gronning, M., et al. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.8.897 · Cited by 741

High performance of cerebrospinal fluid immunoglobulin G analysis for diagnosis of multiple sclerosis

Gamraoui, S., Mathey, G., Debouverie, M., Malaplate, C., Anxionnat, R., Guillemin, F., & Epstein, J. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09212-4 · Cited by 3

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

Stangel, M., Fredrikson, S., Meinl, E., Petzold, A., Stüve, O., & Tumani, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.41 · Cited by 229